This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Ole Dammann
Chief Executive Officer at kfgn|Site Operations & Services GmbH, Germany

Profile

Ole is the CEO at kfgn and member of the Pratia board. He acts as an Advisory Board Member for Clinscience.

kfgn is a group of six sites across Germany conducting clinical trials for the pharmaceutical industry. Together with Pratia the network covers 7 countries with more than 60 sites. At Pratia they are developing a virtual clinical trial platform for the conduction of clinical trials. In cooperation with their partners kfgn and Pratia are driving the digitalization of clinical research.

Ole is currently working on the digitization of clinical research and the development of new business models. He is also engaged in several projects in digital health care.

Agenda Sessions

  • LIVE Panel, Q&A and Audience Interaction: What are the main challenges of AI and what advancements have been made?

    11:05
  • LIVE Panel, Q&A and Audience Interaction: What are the main challenges of AI and what advancements have been made?

    11:05